SCHEMBL3484026

SCHEMBL3484026

COc1ccccc1C(=O)c1ccc(C)cc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.66
STS P08842 1/20 0.63
AKR1C3 P42330 1/20 0.62
GAA P10253 2/20 0.57
TP53 P04637 1/20 0.57
MAPT P10636 3/20 0.56
ALDH1A1 P00352 2/20 0.56
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
LMNA P02545 1/20 0.54
NPC1 O15118 4/20 0.53
TDP1 Q9NUW8 1/20 0.53
CTSD P07339 1/20 0.51
KDM4E B2RXH2 1/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616664 0.89 MAPT (0.69) RAB9ASTSAKR1C3GAATP53
SCHEMBL50229 0.89 MAPT (0.64) RAB9ASTSAKR1C3GAATP53
SCHEMBL29573531 0.89 MAPT (0.64) RAB9ASTSAKR1C3GAATP53
SCHEMBL29291422 0.88 TP53 (0.64) RAB9ASTSAKR1C3GAATP53
SCHEMBL1682193 0.87 STS (0.70) RAB9ASTSGAATP53MAPT
SCHEMBL29771971 0.87 STS (0.70) RAB9ASTSGAATP53MAPT
SCHEMBL1584218 0.87 RAB9A (0.67) RAB9ASTSGAATP53MAPT
SCHEMBL8439039 0.87 ALDH1A1 (0.64) RAB9ASTSAKR1C3GAATP53
SCHEMBL31286496 0.87 RAB9A (0.67) RAB9ASTSGAATP53MAPT
Benzophenone SCHEMBL11416830 0.87 MAPT (0.67) RAB9ASTSAKR1C3GAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
EP-2049107-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES Genfit (FR) 2009-04-22 EP disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 RAB9A 1905/4885STS 439/4885AKR1C3 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.